Rhythm Pharmaceuticals to Present at the Jefferies 2018 Healthcare Conference
BOSTON, June 01, 2018 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM), a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic disorders of obesity, today announced that Keith …